Table 1.
Clinical and biochemical characteristics according to Ad-36 seropositivity.
| Characteristics | Total n = 157 |
Ad-36 negative n = 41 |
Ad-36 positive n = 116 |
P value |
|---|---|---|---|---|
| Age (yr) | 9 (6–11) | 9 (6–11) | 9 (6–11) | 0.68 |
| Gender | 0.19 | |||
| Male | 75 (47.8) | 16 (39.0) | 59 (50.8) | |
| Female | 82 (52.2) | 25 (61.0) | 57 (49.1) | |
| Weight (kg) | 31.5 (20.4–59.1) | 29.2 (20.4–58.5) | 34.1 (20.7–59.1) | 0.28 |
| Height (cm) | 132 (116.6–156) | 132 (118–150) | 131.5 (116.6–158) | 0.38 |
| BMI (kg/m2) | 18.9 (14.4–26.6) | 17.4 (14.8–25.19) | 20.1 (14.4–26.6) | 0.08 |
| Systolic BP (mmHg) | 98 (81–111) | 95 (82–107) | 99 (80–112) | 0.07 |
| Diastolic BP (mmHg) | 58 (49–68) | 58 (50–65) | 59 (48–68) | 0.40 |
| Waist circumference (cm) | 67 (55–88) | 66 (56–86) | 68.25 (55–88) | 0.42 |
| Arm circumference (cm) | 21 (16.5–28) | 20 (17–27) | 21 (16–28) | 0.40 |
| Biceps skinfold (mm) | 15.37 ± 4.64 | 15.52 ± 5.42 | 15.32 ± 4.36 | 0.83 |
| Triceps skinfold (mm) | 14.71 ± 4.03 | 14.87 ± 4.27 | 14.65 ± 3.96 | 0.77 |
| Subscapular skinfold (mm) | 14 (6–22) | 13 (5.5–21.5) | 14.75 (6–22) | 0.44 |
| Suprailiac skinfold (mm) | 17 (9.5–26.5) | 18 (8–25) | 17 (9.5–29) | 0.73 |
| Total cholesterol (mg/dL) | 179.1 ± 30.53 | 172.7 ± 27.45 | 181.5 ± 31.3 | 0.09 |
| Triglycerides (mg/dL) | 90 (36–200) | 87 (36–161) | 93 (36–200) | 0.09 |
| HDL-c (mg/dL) | 53 (27–101) | 55 (28–90) | 52.5 (26–101) | 0.26 |
| LDL-c (mg/dL) | 98.8 (59–174.6) | 97.6 (52–159.8) | 99.3 (60.9–179.5) | 0.59 |
| Glucose (mg/dL) | 95 (75–112) | 94 (73–109) | 97 (79–112) | 0.13 |
| Insulin (µU/mL) | 6.6 (0.79–22.65) | 6.37 (0.09–17.06) | 6.72 (0.79–27.53) | 0.49 |
| HOMA | 1.20 (0–5.47) | 1.01 (0–4.08) | 1.27 (0–6.64) | 0.24 |
The parametric variables are shown means ± SD, median, and percentile 5 and 95 are shown for nonparametric variables. P values were obtained with the Student's t-test and the Mann-Whitney U test. P < 0.05 was statistically significant. BMI: Body mass index; HDL-c: high density lipoprotein-cholesterol; LDL-c, low density lipoprotein-cholesterol; HOMA: The Homeostasis Model Assessment.